Healthcare Triangle, Inc. (HCTI)
Healthcare Triangle, Inc. (HCTI)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Purchase of furniture and equipment | 22 | 0 | 3 | 3 |
| Acquisition of intangible assets | NaN | 215 | 683 | 600 |
| Increase in other non-current assets | NaN | 247 | NaN | NaN |
| Acquisition of teyame | 6,000 | NaN | NaN | NaN |
| Net cash used in investing activities | -6,022 | -462 | -686 | -603 |
| Net proceeds from short-term borrowing | 548 | 10,665 | 423 | -1,674 |
| Net proceeds from long-term debt | 269 | NaN | NaN | NaN |
| Decrease in other long-term liability | -137 | NaN | NaN | NaN |
| Proceeds from equity issuance | 8,881 | 17,032 | NaN | NaN |
| Interest paid | 83 | 100 | 467 | NaN |
| Net proceeds from equity issuance | NaN | NaN | 628 | 13,677 |
| Repayment of convertible note | 0 | NaN | NaN | NaN |
| Net cash provided by financing activities | 9,478 | 13,292 | 584 | 12,003 |
| Cumulative translation adjustment | 98 | NaN | NaN | NaN |
| Net loss | -6,198 | -4,503 | -1,905 | -3,068 |
| Net unrealized exchange gain | NaN | 35 | -8 | NaN |
| Depreciation and amortization | 810 | 630 | 63 | 12 |
| Expenses settled through equity | NaN | 393 | NaN | NaN |
| Change in fair value | 2,435 | NaN | NaN | 0 |
| Other current liabilities | NaN | NaN | 620 | -592 |
| Interest expenses | 89 | 100 | 151 | 316 |
| Advances | NaN | 324 | 182 | 2,823 |
| Interest expenses settled by equity | NaN | NaN | 316 | NaN |
| Bad debt expense | 125 | 37 | -20 | NaN |
| Accounts receivable | 1,542 | -334 | 495 | 752 |
| Other current assets | 1,284 | 3,086 | -93 | 133 |
| Accounts payable | -280 | -111 | -2 | -1,375 |
| Other current liabilities | -1,019 | 265 | NaN | NaN |
| Common stock issued for services | -88 | NaN | 0 | 88 |
| Amortization of debt discount | 0 | 0 | 223 | NaN |
| Other income | 0 | 2 | 559 | 124 |
| Stock compensation expenses | 0 | 0 | 415 | 36 |
| Interest expenses settled by equity | 0 | NaN | NaN | NaN |
| Amortization of debt discount | NaN | NaN | NaN | 223 |
| Contingent consideration | NaN | 100 | NaN | NaN |
| Due from affiliates | 0 | NaN | NaN | NaN |
| Net cash used in operating activities | -6,864 | -6,834 | -1,497 | -8,192 |
| Net increase/(decrease) in cash and cash equivalents | NaN | 5,996 | -1,599 | 3,208 |
| Net increase / (decrease) in cash and cash equivalents | -3,310 | NaN | NaN | NaN |
| Cash and cash equivalents at the beginning of the year | 1,629 | NaN | 20 | NaN |
| Cash and cash equivalents at the end of the period | 4,315 | NaN | 1,629 | NaN |